Zane C. Neal

578 total citations
17 papers, 445 citations indexed

About

Zane C. Neal is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Zane C. Neal has authored 17 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Zane C. Neal's work include Virus-based gene therapy research (6 papers), CAR-T cell therapy research (5 papers) and Immunotherapy and Immune Responses (5 papers). Zane C. Neal is often cited by papers focused on Virus-based gene therapy research (6 papers), CAR-T cell therapy research (5 papers) and Immunotherapy and Immune Responses (5 papers). Zane C. Neal collaborates with scholars based in United States and Germany. Zane C. Neal's co-authors include Paul M. Sondel, Alexander L. Rakhmilevich, Michael Imboden, Stephen D. Gillies, Ralph A. Reisfeld, Jacquelyn A. Hank, Gary A. Splitter, Lyudmila G. Burdelya, Hua Yu and Joel G. Turner and has published in prestigious journals such as The Journal of Immunology, Journal of Virology and Clinical Cancer Research.

In The Last Decade

Zane C. Neal

17 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zane C. Neal United States 12 255 167 162 88 67 17 445
D. Carbone United States 9 261 1.0× 231 1.4× 230 1.4× 28 0.3× 53 0.8× 15 530
Özlem Akilli‐Öztürk Germany 4 183 0.7× 77 0.5× 237 1.5× 10 0.1× 24 0.4× 6 397
Nourredine Himoudi United Kingdom 14 351 1.4× 292 1.7× 164 1.0× 98 1.1× 15 0.2× 18 599
Adri Recio United States 8 333 1.3× 369 2.2× 236 1.5× 27 0.3× 30 0.4× 8 796
M Taniguchi Japan 14 686 2.7× 205 1.2× 146 0.9× 37 0.4× 105 1.6× 33 836
Korina G. Veenstra United States 6 317 1.2× 216 1.3× 139 0.9× 8 0.1× 38 0.6× 8 484
Gerald J. Vosika United States 11 99 0.4× 130 0.8× 93 0.6× 23 0.3× 21 0.3× 24 320
Nathalie Baudson Belgium 11 189 0.7× 269 1.6× 171 1.1× 7 0.1× 119 1.8× 19 520
Lori Clarke United States 8 144 0.6× 159 1.0× 262 1.6× 7 0.1× 51 0.8× 9 456
Céline Robert-Tissot United States 10 255 1.0× 191 1.1× 188 1.2× 7 0.1× 15 0.2× 15 430

Countries citing papers authored by Zane C. Neal

Since Specialization
Citations

This map shows the geographic impact of Zane C. Neal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zane C. Neal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zane C. Neal more than expected).

Fields of papers citing papers by Zane C. Neal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zane C. Neal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zane C. Neal. The network helps show where Zane C. Neal may publish in the future.

Co-authorship network of co-authors of Zane C. Neal

This figure shows the co-authorship network connecting the top 25 collaborators of Zane C. Neal. A scholar is included among the top collaborators of Zane C. Neal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zane C. Neal. Zane C. Neal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wong, So C., Weijun Cheng, Holly Hamilton, et al.. (2017). HIF2α-Targeted RNAi Therapeutic Inhibits Clear Cell Renal Cell Carcinoma. Molecular Cancer Therapeutics. 17(1). 140–149. 27 indexed citations
2.
Buhtoiarov, Ilia N., Zane C. Neal, Jacek Gan, et al.. (2011). Differential internalization of hu14.18-IL2 immunocytokine by NK and tumor cell: impact on conjugation, cytotoxicity, and targeting. Journal of Leukocyte Biology. 89(4). 625–638. 31 indexed citations
3.
Monahan, Sean, et al.. (2007). Rapidly Reversible Hydrophobization: An Approach to High First-Pass Drug Extraction. Chemistry & Biology. 14(9). 1065–1077. 6 indexed citations
4.
Neal, Zane C., et al.. (2007). Hydrodynamic Limb Vein Delivery of a Xenogeneic DNA Cancer Vaccine Effectively Induces Antitumor Immunity. Molecular Therapy. 15(2). 422–430. 15 indexed citations
5.
Neal, Zane C., et al.. (2007). Flt3-L gene therapy enhances immunocytokine-mediated antitumor effects and induces long-term memory. Cancer Immunology Immunotherapy. 56(11). 1765–1774. 11 indexed citations
6.
Neal, Zane C., et al.. (2006). 618. Hydrodynamic Limb Vein-Delivered Xenogeneic Plasmid DNA Cancer Vaccine Effectively Induces Antitumor Protection. Molecular Therapy. 13. S238–S238. 1 indexed citations
7.
Zhang, Guofeng, et al.. (2006). Genetic Immunization for Antibody Generation in Research Animals by Intravenous Delivery of Plasmid DNA. BioTechniques. 40(2). 199–208. 33 indexed citations
8.
Weber, Sharon M., Qi Chen, Zane C. Neal, Paul M. Sondel, & David M. Mahvi. (2004). IL-12 cDNA direct injection: Antimetastatic effect from a single injection in a murine hepatic metastases model. Journal of Surgical Research. 122(2). 210–217. 4 indexed citations
9.
Neal, Zane C., Alexander L. Rakhmilevich, Ilia N. Buhtoiarov, et al.. (2004). Enhanced Activity of Hu14.18-IL2 Immunocytokine against Murine NXS2 Neuroblastoma when Combined with Interleukin 2 Therapy. Clinical Cancer Research. 10(14). 4839–4847. 76 indexed citations
10.
Neal, Zane C., Michael Imboden, Alexander L. Rakhmilevich, et al.. (2003). NXS2 murine neuroblastomas express increased levels of MHC class I antigens upon recurrence following NK-dependent immunotherapy. Cancer Immunology Immunotherapy. 53(1). 41–52. 37 indexed citations
11.
Sondel, Paul M., Jacquelyn A. Hank, Jacek Gan, Zane C. Neal, & Mark R. Albertini. (2003). Preclinical and clinical development of immunocytokines.. PubMed. 4(6). 696–700. 14 indexed citations
12.
Neal, Zane C., et al.. (2002). Encephalomyocarditis and Mengo Viruses Productively Infect Murine T-Lymphocyte Cell Lines But Not Fresh ex Vivo Derived T Lymphocytes. Viral Immunology. 15(1). 155–163. 1 indexed citations
13.
Turner, Joel G., Alexander L. Rakhmilevich, Lyudmila G. Burdelya, et al.. (2001). Anti-CD40 Antibody Induces Antitumor and Antimetastatic Effects: The Role of NK Cells. The Journal of Immunology. 166(1). 89–94. 90 indexed citations
14.
Imboden, Michael, Alexander L. Rakhmilevich, Zane C. Neal, et al.. (2001). The level of MHC class I expression on murine adenocarcinoma can change the antitumor effector mechanism of immunocytokine therapy.. PubMed. 61(4). 1500–7. 40 indexed citations
15.
Neal, Zane C., et al.. (2000). Mengovirus and Encephalomyocarditis Virus Poly(C) Tract Lengths Can Affect Virus Growth in Murine Cell Culture. Journal of Virology. 74(7). 3074–3081. 29 indexed citations
16.
Neal, Zane C. & Gary A. Splitter. (1998). Protection against Lethal Encephalomyocarditis Virus Infection in the Absence of Serum-Neutralizing Antibodies. Journal of Virology. 72(10). 8052–8060. 12 indexed citations
17.
Neal, Zane C. & Gary A. Splitter. (1995). Picornavirus-specific CD4+ T lymphocytes possessing cytolytic activity confer protection in the absence of prophylactic antibodies. Journal of Virology. 69(8). 4914–4923. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Carbone Breakdown of academic impact, for papers by Özlem Akilli‐Öztürk Breakdown of academic impact, for papers by Nourredine Himoudi Breakdown of academic impact, for papers by Adri Recio Breakdown of academic impact, for papers by M Taniguchi Breakdown of academic impact, for papers by Korina G. Veenstra Breakdown of academic impact, for papers by Gerald J. Vosika Breakdown of academic impact, for papers by Nathalie Baudson Breakdown of academic impact, for papers by Lori Clarke Breakdown of academic impact, for papers by Céline Robert-Tissot
Rankless by CCL
2026